Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.

Q4 2024 Earnings Conference Call February 25, 2025 5:00 PM ETCompany ParticipantsRyan Peterson – Investor RelationsKevin Smith ...

Top-line results from SUMMIT trial in NonAdvSM patients expected July 2025• APEX trial enrollment in AdvSM patients complete; top-line results ...

The Trump administration and Elon Musk have insisted that they are carefully purging the federal workforce by firing only low ...

Matthew Kearns: Al Wukair Logistics Park plays a key role in supporting MSMEs ...

Q4 2024 Earnings Call Transcript February 18, 2025 Tactile Systems Technology, Inc. beats earnings expectations. Reported EPS ...

JERUSALEM, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), a pioneer in ...

They also told CNN they fear having their specialized Q security clearance terminated ... role and state they completed the service requirements to obtain career tenure. “The service is losing ...

Rhythm shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast on Wall Street.

Receives FDA authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose clinical study of ENTR-601-44 in adults living with ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The Clinical Kidney Journal in February ...

The best sheds provide additional storage space in the yard for a lawnmower and other tools while also keeping them safe from ...